Logo

Caveat Emptor

Sep 08, 2008

The UK's Times Online reports on the growing market of companies like 23andMe, kicking off with this straight-to-the heart statement: "Leading genetic testing companies are providing clients with widely divergent and inaccurate predictions of their chances of developing serious diseases." The author has used the services of 23andMe, DecodeMe, and British provider GeneticHealth, getting in return "contradictory assessments of the risk I faced of developing illnesses, including Alzheimer's and glaucoma, and a confused verdict on my risk of suffering heart problems."

 

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.